Skip to main content
WELL logo

WELL · Welltower Inc.

Track WELL — free
$242.96 -1.70 (-0.69%)
Market Cap
$179.48B
Shares
733.61M
Volume · Nov 17 295.66K Avg daily vol (3M) 2.73M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$244.65 Open$246.64 Day$244.46–247.46 52W close$181.96–252.07 Avg vol 30d2.9M Short int17.5M · 2.4% of shares · 5.8d Short vol54% Last earningsSep 23, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 27

Up next

Dec 16, 2026 Est · unconfirmed · in 4 wks

Latest documents

2026
Oct 27
Current report 8-K
Other events

On October 27, 2026, Welltower Inc. registered possible issuance of up to 166,666 shares under its Fellowship Grant, 334,938 shares for HCN Canadian Investment (Silver Quebec) LP unit exchanges, and 1,146,886 shares for Welltower OP LLC unit redemptions, subject to applicable conditions.

Read from the first part of this long document
Oct 27
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Welltower Inc. reported nine-month 2026 net income of 1,630,122, FFO of 3,206,992 and NOI of 4,160,720, all in thousands. It sold 315 Outpatient Medical properties under an approximately $7.2 billion portfolio sale, leaving no secured debt in the segment.

Revenue $3.72B ▲ 38.4% Net income $414.82M ▲ 47.0% Diluted EPS $0.54 ▲ 31.7%
Read from the MD&A section
Oct 26
Current report 8-K
Financial results, Regulation FD disclosure

Welltower reported third-quarter normalized FFO of $1.67 per diluted share and 15.8% same-store NOI growth. It raised 2026 normalized FFO guidance to $6.47-$6.53 per diluted share and net income guidance to $3.31-$3.37 per diluted share.

Read from the first part of this long document
Sep 23
Earnings call
Q3 2026 earnings call

Welltower reported 38% revenue growth, 35% adjusted EBITDA growth and nearly 25% FFO per share growth, raised full-year normalized FFO guidance to $6.47 to $6.53 per diluted share, and completed or announced over $21 billion of year-to-date investment activity.

Read from the first part of this long document
Jul 28
Current report 8-K
Other events AI summary on its way
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$13.79B
Trailing 12 months
Net income (TTM)
$1.75B
Trailing 12 months
Revenue growth YoY
+38.4%
Year over year
Operating margin
—
Trailing 12 months
P / FFO
68.7×
Company-stated · TTM · reciprocal yield 1.5%
P / E (TTM)
106.3
Trailing earnings · reciprocal yield 0.9%
Return on invested capital
—
Trailing 12 months
Net cash
−$15.88B
Latest balance sheet
Dividend yield
1.3%
Trailing 12 months
Shares change YoY
+10.1%
Year over year · more shares
Price change (1Y)
+27.9%
Trailing year
Short interest
2.4%
Latest settlement · 5.8 days to cover
View all 129 metrics

AI Brief

Q2 FY26 earnings call · Jun 23, 2026
Q2 FY26

TL;DR. Welltower reported a 25.0% YoY rise in normalized FFO per share to $1.60, with 20.5% SHO same-store NOI growth, and raised full-year normalized FFO guidance to $6.36–$6.44 per share while lowering net income guidance to $3.11–$3.19 per share. The Board also increased the quarterly dividend 15% to $0.85.

Bullish
  • + Normalized FFO per share rose 25.0% YoY to $1.60 in Q2
  • + Total SSNOI grew 15.5% YoY, led by SHO SSNOI growth of 20.5%
  • + Raised full-year normalized FFO guidance to $6.36–$6.44 per share from $6.21–$6.35
  • + Quarterly dividend increased 15% to $0.85, citing confidence in cash flow durability and balance sheet strength
  • + Strong SHO organic growth with 9.2% revenue growth, 330 bps occupancy growth and 5.2% RevPOR growth
  • + Year-to-date closed or under contract $15.5 billion of pro rata gross investments at attractive yields
Bearish
  • − Lowered full-year net income attributable to common stockholders guidance to $3.11–$3.19 per share from $3.24–$3.38
  • − Impairment of assets of $25.8 million in Q2

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very Low
Market backdrop VIX 22.9 · elevated Equity put/call 0.73
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +10%
above
Price vs 50-day avg +4%
above
RSI (14) 58
neutral
MACD trend Positive
52-week position 89%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +5%
trailing
6-month return +14%
trailing
YTD return +32%
this year
Relative strength +16%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $235 › 200d $222 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +150 funds added
Insider flow Accumulating
Net +$2.4M over 90 days · 0% sells
Short interest Rising
2.38% of shares out · ▲ +4.7% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,640 holders — near 3-yr high, broad support
Squeeze score 64
elevated · 0–100
Fundamentals
Weak
Revenue growth +36%
Y/Y
EPS growth −11%
Y/Y
Valuation P/E 106.4
rich
Buyback $3.0B
remaining
Balance sheet $14.2B
net debt
Quant / Vol
risk profile
Very Low
Volatility 23%
annualized · 1-yr
Max drawdown −13%
past year
ATR 2.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Oct 27, 2026
full year
Year-over-year growth 23%
remaining
Investment activity $7.7B
full year 2026
Net income attributable to common stockholders Maintained $3.31 – $3.37
Oct 26, 2026 $3.31 – $3.37 changed to Oct 27, 2026 $3.31 – $3.37
prior FY $1.39 midpoint +140.3% Y/Y
Normalized FFO per diluted share Non-GAAP $6.47 – $6.53
Total portfolio year-over-year same-store NOI growth Raised 15% – 16.25%
Jul 28, 2026 13.75% – 16% changed to Oct 27, 2026 15% – 16.25%
Expense growth Maintained 4.6%
Sep 23, 2026 4.6% changed to Oct 27, 2026 4.6%
Normalized FFO Non-GAAP $6.47 – $6.53
2026
Normalized FFO per share growth Non-GAAP Maintained 22.9%
Sep 23, 2026 22.9% changed to Oct 27, 2026 22.9%
Previous outlook earlier release · from the 8-K filed Oct 26, 2026

Still-open targets the latest release did not restate under the same label.

Normalized FFO attributable to common stockholders · full year $6.47 – $6.53
Average blended SSNOI growth · 2026 15% – 16.25%
Seniors Housing Operating · 2026 20.25% – 21.75%
Seniors Housing Triple-net · 2026 3.5% – 4.5%
Skilled Nursing · 2026 2% – 3%
Outpatient Medical · 2026 2% – 3%
General and Administrative Expenses · 2026 $267M – $272M
Stock-based compensation expense · 2026 $60M
Pro rata disposition proceeds · next twelve months $1.9B
Consideration from expected property sales · next twelve months $1.5B
Blended yield · next twelve months 6.5%
Expected proceeds from loan repayments · next twelve months $328M
Senior Housing Operating · FY2026 20.25% – 21.75%
Total Portfolio · FY2026 15% – 16.25%
Full-year RevPOR growth · 2026 5.1%
SS revenue growth · 2026 9.3%
SS expense growth · 2026 4.6%
ExpPOR growth · 2025 to 2026 0.6%
Normalized FFO · Year Ending December 31, 2026 $6.47 – $6.53
Normalizing items, net(1,2) · Year ending December 31, 2026 $298M
Recurring cap-ex(3) · Year ending December 31, 2026 $-465M
Stock-based compensation · Year ending December 31, 2026 $63M
NAREIT FFO attributable to common stockholders · Year ending December 31, 2026 $4.54B – $4.58B
Net straight-line rent and above/below market rent amortization · Year ending December 31, 2026 $-342M
Net income attributable to common stockholders · Year ending December 31, 2026 $2.47B – $2.52B
ExpPOR growth · 2026 0.6%
NAREIT FFO · Year ending December 31, 2026 $6.07 – $6.13
Non-cash interest expenses · Year ending December 31, 2026 $51M
Depreciation and amortization(1) · Year ending December 31, 2026 $2.93B
Normalized FFO attributable to common stockholders · Year ending December 31, 2026 $4.83B – $4.88B
Prior guidance period ended · from the Earnings Call filed Apr 29, 2026
Sales · second quarter $500M
Remaining sales · during the second quarter $500M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 3 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+10% Bullish
Price vs 50-day avg
+4% Bullish
RSI (14)
58 Neutral
MACD trend
Positive Bullish
52-week position
89% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $235 › 200d $222 — 50d above 200d
Institutional flow Accumulating
+1% holders QoQ · +150 funds added
Insider flow Accumulating
Net +$2.4M over 90 days · 0% sells
Short interest Rising
2.38% of shares out · ▲ +4.7% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,640 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $182 Now $245 · 89% Range high $252
vs 200-day avg +10% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Net income (loss) $414.82M
-$114.68M Loss (gain) on real estate dispositions and acquisitions of controlling interests, net
+$30.69M Loss (income) from unconsolidated entities
+$7.12M Income tax expense (benefit)
+$124.69M Other expenses
+$33.45M Impairment of assets
+$230K Provision for loan losses, net
+$6.82M Loss (gain) on extinguishment of debt, net
+$0K Loss (gain) on derivatives and financial instruments, net
+$67.17M General and administrative expenses
+$706.79M Depreciation and amortization
+$192.66M Interest expense
= Consolidated net operating income (NOI) $1.47B
Average occupancy 87.6% the three months ended June 30, 2026 filing —
FFO non-GAAP 1.15B Three Months Ended June 30, 2026 filing —
Fixed charge coverage ratio 6.76 Three Months Ended June 30, 2026 filing —
Interest coverage ratio non-GAAP 7.52 the three months ended June 30, 2026 filing —
Net debt to book capitalization ratio 25% Three Months Ended June 30, 2026 filing —
Net debt to enterprise value ratio 9% Three Months Ended June 30, 2026 filing —
Net debt to undepreciated book capitalization ratio 21% Three Months Ended June 30, 2026 filing —
NICS 445M Three Months Ended June 30, 2026 filing —
NOI non-GAAP $1.31B Three Months Ended June 30, 2026 filing —
NOI by segment: Non-segment/Corporate non-GAAP $81.7M Three Months Ended June 30, 2026 filing —
NOI by segment: Outpatient Medical non-GAAP $38.03M Three Months Ended June 30, 2026 filing —
NOI by segment: Seniors Housing Operating non-GAAP $867.23M Three Months Ended June 30, 2026 filing —
NOI by segment: Triple-net non-GAAP $407.5M Three Months Ended June 30, 2026 filing —
Same store properties (QTD Pool) non-GAAP 499 Three Months Ended June 30, 2026 filing —
Same store properties (QTD Pool) - Outpatient Medical non-GAAP 89 Three Months Ended June 30, 2026 filing —
Seniors Housing Operating Property mix 66% Three Months Ended June 30, 2026 filing —
SSNOI non-GAAP $805.82M the three months ended June 30, 2026 filing —
SSNOI at Welltower Share - Outpatient Medical non-GAAP $26.9M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
Consolidated NOI 38.03M (non-GAAP)
+4.45M NOI attributable to unconsolidated investments
-969K NOI attributable to noncontrolling interests
-11.58M NOI attributable to non-same store properties
-3.04M Non-cash NOI attributable to same store properties
= SSNOI at Welltower Share - Outpatient Medical 26.9M
SSNOI at Welltower Share - Seniors Housing Operating non-GAAP $582.62M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
Consolidated NOI 867.23M (non-GAAP)
+21.13M NOI attributable to unconsolidated investments
-15.46M NOI attributable to noncontrolling interests
-288.15M NOI attributable to non-same store properties
-1.29M Non-cash NOI attributable to same store properties
-833K Currency and ownership adjustments
= SSNOI at Welltower Share - Seniors Housing Operating 582.62M
SSNOI at Welltower Share - Total non-GAAP $805.82M Three Months Ended June 30, 2026 filing —
SSNOI at Welltower Share - Triple-net non-GAAP $196.31M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
Consolidated NOI 407.5M (non-GAAP)
-1.03M NOI attributable to noncontrolling interests
-172.51M NOI attributable to non-same store properties
-37.39M Non-cash NOI attributable to same store properties
-259K Currency and ownership adjustments
= SSNOI at Welltower Share - Triple-net 196.31M
SSNOI property count: Outpatient Medical (consolidated) non-GAAP 54 Three Months Ended June 30, 2026 filing —
SSNOI property count: Outpatient Medical (unconsolidated) non-GAAP 73 Three Months Ended June 30, 2026 filing —
SSNOI property count: Seniors Housing Operating (consolidated) non-GAAP 1,869 Three Months Ended June 30, 2026 filing —
SSNOI property count: Seniors Housing Operating (unconsolidated) non-GAAP 125 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total non-GAAP 2,950 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total (consolidated) non-GAAP 2,752 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total (unconsolidated) non-GAAP 198 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total Outpatient Medical non-GAAP 127 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total Seniors Housing Operating non-GAAP 1,994 Three Months Ended June 30, 2026 filing —
SSNOI property count: Total Triple-net non-GAAP 829 Three Months Ended June 30, 2026 filing —
SSNOI property count: Triple-net (consolidated) non-GAAP 829 Three Months Ended June 30, 2026 filing —
Triple-net Property mix 31% Three Months Ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
WELL
Welltower Inc.
this stock
$179.48B +31.8% +35.6% 106.4 2.4%
VTR
Ventas, Inc.
$47.00B +14.9% +18.5% 167.7 2.8%
OHI
Omega Healthcare Investors Inc
$14.33B +6.2% +13.2% 18.9 4.8%
DOC
Healthpeak Properties, Inc.
$13.68B +23.4% +4.5% 36.7 3.3%
AHR
American Healthcare REIT, Inc.
$13.48B +23.4% +9.1% 116.1 14.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1,640
% held
95.1%
Net QoQ
-11.4M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
1,036
View
Short & Settlement
Short Interest Rising
Shares short
17.5M
Days to cover
5.8d
Change
+785.7K sh
View
Short Volume
Short vol %
54%
As of
Nov 16, 2026
Short Total
View
Fails to Deliver
FTD shares
77
Value
$18.3K
As of
Oct 26, 2026
View
Off-Exchange
Off-exchange %
48.4%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$2.4M
Buyers / Sellers
1 / 0
Buyers Sellers
View
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 30, 2026
View
Financials
Financials
Revenue (FY)
$10.8B
Net income (FY)
$936.8M
EPS diluted
$1.39
View
Buybacks
Authorized
$3.0B
Remaining
$3.0B
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 27, 2026
This year
18

Welltower Inc. reported nine-month 2026 net income of 1,630,122, FFO of 3,206,992 and NOI of 4,160,720, all in thousands. It sold 315 Outpatient Medical properties under an approximately $7.2 billion portfolio sale, leaving no secured debt in the segment.

View
Proposed Sales
Value
$605.4K
Shares
4.0K
Filed
Apr 30, 2025
View
Earnings & Events
Webcasts
Last webcast
Sep 23, 2026
View
Investor Relations
Latest news
Welltower Issues Business Update
Published
Oct 26, 2026
View

Performance

5D 20D 120D MTD YTD
WELL -1.1% +4.8% +14.2% +4.3% +31.8%
SPY -1.7% -3.5% -1.4% -2.1% +8.5%
vs SPY +0.6% +8.2% +15.6% +6.4% +23.3%

Capital returns

Latest dividend
$0.85 / share · ex Nov 10, 2026
Raised 14.9%
Paid (TTM)
$3.18 / share · 4 payouts
Dividend yield (TTM, derived)
1.30%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$3.00B
Spent (derived)
$0
Remaining
$3.00B
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 766704 CUSIP 95040Q104 13F (30d) 1525 filings 1430 filers Visit website Investor relations